Microstructural Abnormalities Were Found in Brain Gray Matter from Patients with Chronic Myofascial Pain

• Main Authors: Peng Xie, Bangyong Qin, Ganjun Song, Yi Zhang, Song Cao, Jin Yu, Jianjiang Wu, Jiang Wang, Tijiang Zhang, Xiaoming Zhang, Tian Yu, Hong Zheng
• Format: Article
• Language: English
• Published: Frontiers Media S.A. 2016-12-01
• Series: Frontiers in Neuroanatomy
• Subjects: Chronic Pain; gray matter; diffusion kurtosis imaging; Myofascial trigger points; microstructural abnormalities
• Online Access: http://journal.frontiersin.org/Journal/10.3389/fnana.2016.00122/full

Myofascial pain, presented as myofascial trigger points (MTrPs)-related pain, is a common, chronic disease involving skeletal muscle, but its underlying mechanisms have been poorly understood. Previous studies have revealed that chronic pain can induce microstructural abnormalities in the cerebral gray matter. However, it remains unclear whether the brain gray matter of patients with chronic MTrPs-related pain undergo alteration. In this study, we employed the Diffusion Kurtosis Imaging (DKI) technique, which is particularly sensitive to brain microstructural perturbation, to monitor the MTrPs-related microstructural alterations in brain gray matter of patients with chronic pain. Our results revealed that, in comparison with the healthy controls, patients with chronic myofascial pain exhibited microstructural abnormalities in the cerebral gray matter and these lesions were mainly distributed in the limbic system and the brain areas involved in the pain matrix. In addition, we showed that microstructural abnormalities in the right anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC) had a significant negative correlation with the course of disease and pain intensity. The results of this study demonstrated for the first time that there are microstructural abnormalities in the brain gray matter of patients with MTrPs-related chronic pain. Our findings may provide new insights into the future development of appropriate therapeutic strategies to this disease.